Xenetic Biosciences plc is a leading UK-based biopharmaceutical company providing cutting edge expertise in the development of a completely new generation of drugs and vaccines. We are actively developing our own pipeline of next generation biotherapeutics based on our proprietary PolyXen and ImuXen technologies. We also work in partnership with some of the largest pharmaceutical and biotech organisations in the world, providing specialist delivery solutions to improve the efficacy and performance of biologic drugs and vaccines in a number of key medical areas.
www.xeneticbio.com